NSPR logo

NSPR
InspireMD Inc

34,397
Mkt Cap
$56.74M
Volume
34,077.00
52W High
$2.93
52W Low
$1.12
PE Ratio
-1.43
NSPR Fundamentals
Price
$1.14
Prev Close
$1.21
Open
$1.21
50D MA
$1.58
Beta
0.41
Avg. Volume
48,746.88
EPS (Annual)
-$0.7584
P/B
0.90
Rev/Employee
$70,700.79
$63.58
Loading...
Loading...
News
all
press releases
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·15d ago
News Placeholder
More News
News Placeholder
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)
InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·21d ago
News Placeholder
InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?
InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...
MarketBeat·21d ago
News Placeholder
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC
Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·2mo ago
News Placeholder
Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR
Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·2mo ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
NeuroPace (NPCE) delivered earnings and revenue surprises of +41.48% and +2.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
Penumbra (PEN) delivered earnings and revenue surprises of +5.36% and +6.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR
Aberdeen Group plc bought a new stake in shares of InspireMD, Inc. (NYSE:NSPR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·2mo ago
<
1
2
...
>

Latest NSPR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.